rs761396172
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_004482.4(GALNT3):c.516-2A>T variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_004482.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- tumoral calcinosis, hyperphosphatemic, familial, 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- tumoral calcinosis, hyperphosphatemic, familial, 1Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALNT3 | ENST00000392701.8 | c.516-2A>T | splice_acceptor_variant, intron_variant | Intron 2 of 10 | 1 | NM_004482.4 | ENSP00000376465.3 | |||
GALNT3 | ENST00000715282.1 | c.516-2A>T | splice_acceptor_variant, intron_variant | Intron 2 of 10 | ENSP00000520447.1 | |||||
GALNT3 | ENST00000412248.5 | c.516-2A>T | splice_acceptor_variant, intron_variant | Intron 3 of 7 | 5 | ENSP00000412643.1 | ||||
GALNT3 | ENST00000437849.1 | n.-99A>T | upstream_gene_variant | 5 | ENSP00000391104.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152224Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 250868 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460782Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726768 show subpopulations
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74370 show subpopulations
ClinVar
Submissions by phenotype
Tumoral calcinosis, hyperphosphatemic, familial, 1 Pathogenic:2
- -
- -
not provided Pathogenic:2
Canonical splice site that results in a null allele in a gene for which loss of function is a known mechanism of disease (PMID: 18618993); This variant is associated with the following publications: (PMID: 25525159, 18618993, 27164190, 29625052, 15687324) -
This sequence change affects an acceptor splice site in intron 2 of the GALNT3 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GALNT3 are known to be pathogenic (PMID: 15133511, 20358599). This variant is present in population databases (no rsID available, gnomAD 0.04%). Disruption of this splice site has been observed in individual(s) with tumoral calcinosis (PMID: 15687324, 27164190). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as IVS1-2a>t. ClinVar contains an entry for this variant (Variation ID: 7794). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at